GSK PLC Sponsored ADR (GSK)
(Delayed Data from NYSE)
$40.80 USD
-0.82 (-1.97%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $40.80 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
GSK (GSK) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$46.38 | $54.00 | $39.30 | 11.44% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for GSK comes to $46.38. The forecasts range from a low of $39.30 to a high of $54.00. The average price target represents an increase of 11.44% from the last closing price of $41.62.
Analyst Price Targets (6 )
Broker Rating
GSK currently has an average brokerage recommendation (ABR) of 2.36 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms. The current ABR compares to an ABR of 2.42 a month ago based on 12 recommendations.
Of the 14 recommendations deriving the current ABR, six are Strong Buy, representing 42.86% of all recommendations. A month ago, Strong Buy represented 41.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 5 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 6 | 6 | 5 | 5 | 4 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 2 |
ABR | 2.36 | 2.36 | 2.42 | 2.55 | 2.73 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/18/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
9/16/2024 | Goldman Sachs | Rajan Sharma | Hold | Hold |
8/27/2024 | Not Identified | Not Identified | Not Available | Hold |
8/7/2024 | Argus Research Corp. | Jasper Hellweg | Not Available | Strong Buy |
7/31/2024 | Not Identified | Not Identified | Hold | Hold |
7/8/2024 | UBS | Alexandra M Hauber | Strong Sell | Hold |
7/2/2024 | Cowen & Co. | Steve M Scala | Hold | Hold |
6/24/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
6/20/2024 | Berenberg Bank | Kerry Holford | Not Available | Strong Buy |
3/4/2024 | Guggenheim Securities | Seamus Fernandez | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.36 |
ABR (Last week) | 2.36 |
# of Recs in ABR | 14 |
Average Target Price | $46.38 |
LT Growth Rate | 7.50% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | 1.23 |
GSK FAQs
GSK PLC Sponsored ADR (GSK) currently has an average brokerage recommendation (ABR) of 2.36 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms.
The average price target for GSK PLC Sponsored ADR (GSK) is $46.38. The current on short-term price targets is based on 7 reports.
The forecasts for GSK PLC Sponsored ADR (GSK) range from a low of $39.3 to a high of $54. The average price target represents a increase of $13.68 from the last closing price of $40.80.
The current UPSIDE for GSK PLC Sponsored ADR (GSK) is 13.68%
Based on short-term price targets offered by six analysts, the average price target for GSK comes to $46.38. The forecasts range from a low of $39.30 to a high of $54.00. The average price target represents an increase of 11.44% from the last closing price of $41.62.